trastuzumab,neratinib
roche,knight therapeutics,pierre fabre,puma
['summit', 'neratinib', 'puma', 'biotec']
puma biotechnology presents final results from the biliary tract cohort of the phase 2 summit basket trial of neratinib at the asco 2022 annual meeting 
Pharmaceutical News - Direct Information